Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naive patients with type 2 diabetes - Kadoglou, N P; Kapelouzou, A; Tsanikidis, H; Vitta, I; Liapis, C D; Sailer, N (Exp Clin Endocrinol Diabetes, 2011)